General MedicationsORALGeneric

KETOPROFEN

Standard Dose

12.5MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview KETOPROFEN is listed in Drugs@FDA under application 075364 (ANDA).

Marketing status: Discontinued Active ingredient KETOPROFEN Form and strength TABLET;ORAL - 12.5MG Sponsor PERRIGO Submission history Latest submission status date: 2002-02-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview KETOPROFEN is listed in Drugs@FDA under application 075364 (ANDA). Marketing status: Discontinued Active ingredient KETOPROFEN Form and strength TABLET;ORAL - 12.5MG Sponsor PERRIGO Submission history Latest submission status date: 2002-02-07 00:00:00. Submission type: ORIG.

Monitoring

• Review priority: STANDARD
• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.